KLDO News and Press, Kaleido Biosciences Inc. From 05/14/20

Kaleido Biosciences (NASDAQ: KLDO ): Q1 GAAP EPS of -$0.64 in-line. More news on: Kaleido Biosciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

- Initiating Clinical Studies of KB109 in Outpatients with Mild-to-Moderate COVID-19; Data Anticipated in Q4 2020 - - Expanding Work in Immune-Mediated and Inflammatory Diseases; Data from New Clinical Study in Ulcerative Colitis Expected in Mid-2021 - - Conference Call Scheduled...

- Top-Line Data from Study of Approximately 350 Patients Expected in Q4 2020 -             - Second Clinical Study Expected to Initiate Shortly with Similar Design and Additional Microbiome Analysis - LEXINGTON, Mass., May...

LEXINGTON, Mass., May 12, 2020 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a chemistry-driven approach to leveraging the microbiome organ to treat disease and improve human health, today announced that it plans to release first quar...

LEXINGTON, Mass., April 03, 2020 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a chemistry-driven approach to leveraging the microbiome organ to treat disease and improve human health, today announced the appointment of Anne Prene...

LEXINGTON, Mass., March 10, 2020 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a chemistry-driven approach to leveraging the microbiome organ to treat disease and improve human health, today announced that Alison Lawton, President and...

Gainers: Trans World Entertainment TWMC  +260% . More news on: Kaleido BioSciences, Inc., SLM Corporation, Bat Group, Inc., , , Stocks on the move Read more ...

The following slide deck was published by Kaleido BioSciences, Inc. in conjunction with this Read more ...

It used to be that healthcare companies released news at the J.P. Morgan Healthcare Conference. In the last few years, the Friday before the conference became a news dump. Now, the whole week before the conference has become a news extravaganza. The conference is starting later in January t...

Kaleido Biosciences ( KLDO -4.4% ) will collaborate with Johnson & Johnson ( JNJ +0.2% ) unit Janssen Biotech to explore the potential of Kaleido's Microbiome Metabolic Therapies (MMT) to prevent childhood allergies and other atopic immune and metabolic conditions via driving speci...